Update on Business Immunity to COVID-19 Lawsuits

by Kaleem Ahmed, Biotechnology Expert   The focus and hype surrounding vaccines have never been as significant as they are right now. The global vaccine market is set to reach around $58.4 billion by 2024 from $41.7 billion in 2019,…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Li Yifei Ph. D., Electrification & Battery System Engineer, Former Research Assistant from the University of Houston. On July 1st, the three major US stock indexes rose, and technology stocks collectively gained. Tesla alone rose nearly 7%, and its…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Gary Chodes, Litigation Finance Industry Pioneer and founder of industry leaders Oasis, Courthouse Investments and Signal Funding We are now seeing substantial litigation financing activity involving brand name hedge funds players as well as publicly-traded closed-end funds and business…

Read More

Update on Business Immunity to COVID-19 Lawsuits

by Nick Bayard, President & CEO, Bayard Consulting At a quarter of a trillion dollars, the market for impact investing is enormous and rapidly growing. Investors who expect a double or triple bottom line are expecting those who steward their…

Read More

Update on Business Immunity to COVID-19 Lawsuits

Mass marketing won’t cut it as targeting on social media continues to grow by Ben Legg, CEO of AdParlor  As the buzz around Snap’s IPO dies down, it is crucial to look beyond its launch and to its advertising. Is…

Read More